Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corcept Therapeutics

    NASDAQ: CORT · Real-Time Price · USD
    71.72
    -0.28 (-0.39%)
    At close: Aug 15, 2025, 3:59 PM
    71.75
    0.03%
    After-hours: Aug 15, 2025, 04:54 PM EDT

    Corcept Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 141.21M 106.14M 101.42M 112.51M
    Depreciation & Amortization
    		 1.34M 2.36M 2.97M 3.07M
    Stock-Based Compensation
    		 61.35M 48.94M 42.44M 42.93M
    Other Working Capital
    		 46.09M 11.24M 3.49M 1.52M
    Other Non-Cash Items
    		 -10.94M -9.13M 1.38M 5.09M
    Deferred Income Tax
    		 -40.19M -29.49M -33.91M 4.35M
    Change in Working Capital
    		 45.3M 8.22M 6.02M -57K
    Operating Cash Flow
    		 198.07M 127.04M 120.32M 167.89M
    Capital Expenditures
    		 -2.17M -139K -413K -469K
    Cash Acquisitions
    		 n/a n/a 113.91M -136.59M
    Purchase of Investments
    		 -588.31M -328.75M -355.07M -312.81M
    Sales Maturities Of Investments
    		 412.88M 419.79M 241.15M 449.4M
    Other Investing Acitivies
    		 n/a n/a -113.91M 136.59M
    Investing Cash Flow
    		 -177.6M 90.91M -114.33M 136.13M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 -15.66M -145.43M -21.66M -295.99M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -28.35M -3.29M 4.38M -6.61M
    Financial Cash Flow
    		 -28.35M -148.72M -17.28M -302.59M
    Net Cash Flow
    		 -7.89M 69.22M -11.29M 1.43M
    Free Cash Flow
    		 195.9M 126.9M 119.91M 167.42M

    Add to Watchlist